Tizanidine
Product Images NDC 53002-1418

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53002-1418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

Chemical structure of the active ingredient Tizanidine as shown in the image. The structure depicts the molecular arrangement including chlorine and sulfur atoms, consistent with Tizanidine hydrochloride.*

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four conditions: 4 mg Tizanidine tablets with and without food, and 4 mg Tizanidine capsules with and without food, tracking changes in concentration up to 24 hours post-dose.*

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

A line graph showing improvement in Ashworth Score over time in hours post-dose. It compares three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph illustrates the trend of increasing improvement with higher dose and time, including error bars for variability at each time point up to 6 hours.*

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

A line graph depicting improvement in Ashworth Score over three time points: end of titration (study week 3), end of maintenance (study week 7), and endpoint (last observation carried forward). Two groups are shown: tizanidine (mean dose 28.8 mg) with square markers, showing greater improvement, and placebo with circular markers, showing less improvement, along with error bars for variability.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Label Image (Lbl530021418)

Tizanidine 2 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label includes directions to take one tablet three times a day or as directed, and states the quantity as 30 tablets per bottle. Additional label information includes lot number, expiration date, and storage instructions, along with barcodes and spaces for clinic and patient details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.